CI

At a glance

ClinicalIndex Comparison Record
Phase 1Completed· 24 enrolled
Drug / intervention
LY900014drug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02752087
NCT02752087Phase 1Completed
CompareCT.gov

A Study to Compare the Pharmacokinetics and Pharmacodynamics of LY900014 Test Versus Reference Formulations in Healthy Subjects

Eli Lilly and Company·interventional·Posted Apr 26, 2016·Updated May 1, 2020

In Brief

A Phase 1 clinical trial evaluating LY900014 for Healthy. Completed, enrolled 24 participants across 1 site.

Detailed Summary

This study of healthy participants evaluated the concentration of a test LY900014 and a reference LY900014 formulation in the bloodstream and how it affected the blood sugar levels. The whole study, including screening, took up to 8 weeks to complete.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy
CountriesSingapore
Collaborators--

Timeline

Phase 1CompletedFinished
20162017201820192020202120222023202420252026
First PostedApr 26, 2016
Enrollment StartApr 1, 2016
Primary CompletionMay 1, 2016
TodayJul 2, 2026
Enrollment to primary: 1 monthPosted 10.2 years ago

Interventions

LY900014drug

Administered SC